Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming-Reference-Cited by-同舟云学术

Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming

Published:2021-08-02 Issue:6 Volume:290 Page:1272-1274
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Hansen Cecilie Bo¹^ORCID,Jarlhelt Ida¹,Hasselbalch Rasmus Bo²³,Hamm Sebastian Rask⁴,Fogh Kamille²³,Pries‐Heje Mia Marie⁵,Møller Dina Leth⁴,Heftdal Line Dam⁴⁶,Pérez‐Alós Laura¹,Sørensen Erik⁷,Larsen Margit Anita Hørup⁷,Skjoedt Mikkel‐Ole¹,Ostrowski Sisse Rye⁷⁸,Frikke‐Schmidt Ruth⁸⁹^ORCID,Bayarri‐Olmos Rafael¹,Hilsted Linda Maria⁹,Bundgaard Henning⁶⁸,Nielsen Susanne Dam⁴⁸,Iversen Kasper Karmark²³⁸,Garred Peter¹⁸^ORCID

Affiliation:

1. Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631 Rigshospitalet, University of Copenhagen Copenhagen Denmark

2. Department of Cardiology, Herlev and Gentofte Hospital University of Copenhagen Copenhagen Denmark

3. Department of Emergency medicine, Herlev and Gentofte Hospital University of Copenhagen Denmark

4. Department of Infectious Diseases Rigshospitalet, University of Copenhagen Copenhagen Denmark

5. Department of Cardiology Rigshospitalet, University of Copenhagen Copenhagen Denmark

6. Department of Haematology Rigshospitalet, University of Copenhagen Copenhagen Denmark

7. Department of Clinical Immunology, Section 2034 Blood Bank Rigshospitalet, University of Copenhagen Copenhagen Denmark

8. Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

9. Department of Clinical Biochemistry Rigshospitalet, University of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13366

Reference9 articles.

1. SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain

2. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals

3. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

4. Immunosenescence and vaccine failure in the elderly

5. The Xs and Y of immune responses to viral vaccines

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies;Viruses;2023-12-20

2. Diverging humoral and cellular immune responses due to Omicron—a national study from the Faroe Islands;Microbiology Spectrum;2023-12-12

3. Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis;Journal of Neuroimmunology;2023-11

4. Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodies;Microbiology Spectrum;2023-10-17

5. Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk;Nature Communications;2023-09-12